The Progress and Future of US Newborn Screening

The Progress and Future of US Newborn Screening

Progress in newborn screening (NBS) has been driven for 60 years by developments in science and technology, growing consumer advocacy, the actions of providers involved in the care of rare disease patients, and by federal and State government funding and policies. With the current explosion of clini...

Full description

Bibliographic Details
Main Authors: Michael S. Watson, Michele A. Lloyd-Puryear, R. Rodney Howell
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:International Journal of Neonatal Screening
Subjects:
newborn screening
clinical trials
genetic testing
public health
public health policy
Online Access:https://www.mdpi.com/2409-515X/8/3/41

Similar Items

Similar Items